Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 360 entries
Sorted by: Best Match Show Resources per page
Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells.

Biology of sex differences

Addis R, Campesi I, Fois M, Capobianco G, Dessole S, Fenu G, Montella A, Cattaneo MG, Vicentini LM, Franconi F.
PMID: 25535548
Biol Sex Differ. 2014 Dec 14;5(1):18. doi: 10.1186/s13293-014-0018-2. eCollection 2014.

BACKGROUND: Human umbilical endothelial cells (HUVECs) are widely used to study the endothelial physiology and pathology that might be involved in sex and gender differences detected at the cardiovascular level. This study evaluated whether HUVECs are sexually dimorphic in...

Cite
Addis R, Campesi I, Fois M, et al. Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells. Biol Sex Differ. 2014;5(1):18doi: 10.1186/s13293-014-0018-2.
Addis, R., Campesi, I., Fois, M., Capobianco, G., Dessole, S., Fenu, G., Montella, A., Cattaneo, M. G., Vicentini, L. M., & Franconi, F. (2014). Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells. Biology of sex differences, 5(1), 18. https://doi.org/10.1186/s13293-014-0018-2
Addis, Roberta, et al. "Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells." Biology of sex differences vol. 5,1 (2014): 18. doi: https://doi.org/10.1186/s13293-014-0018-2
Addis R, Campesi I, Fois M, Capobianco G, Dessole S, Fenu G, Montella A, Cattaneo MG, Vicentini LM, Franconi F. Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells. Biol Sex Differ. 2014 Dec 14;5(1):18. doi: 10.1186/s13293-014-0018-2. eCollection 2014. PMID: 25535548; PMCID: PMC4273493.
Copy Download .nbib Format: NLM
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine.

Open forum infectious diseases

Chamcha V, Kannanganat S, Gangadhara S, Nabi R, Kozlowski PA, Montefiori DC, LaBranche CC, Wrammert J, Keele BF, Balachandran H, Sahu S, Lifton M, Santra S, Basu R, Moss B, Robinson HL, Amara RR.
PMID: 27006959
Open Forum Infect Dis. 2016 Feb 11;3(1):ofw034. doi: 10.1093/ofid/ofw034. eCollection 2016 Jan.

Background.  In this study, we analyzed the protective efficacy of a simian immunodeficiency virus (SIV) macaque 239 (SIVmac239) analogue of the clinically tested GOVX-B11 deoxyribonucleic acid (DNA)/modified vaccinia Ankara (MVA) human immunodeficiency virus vaccine. Methods.  The tested vaccine used...

Cite
Chamcha V, Kannanganat S, Gangadhara S, et al. Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine. Open Forum Infect Dis. 2016;3(1):ofw034doi: 10.1093/ofid/ofw034.
Chamcha, V., Kannanganat, S., Gangadhara, S., Nabi, R., Kozlowski, P. A., Montefiori, D. C., LaBranche, C. C., Wrammert, J., Keele, B. F., Balachandran, H., Sahu, S., Lifton, M., Santra, S., Basu, R., Moss, B., Robinson, H. L., & Amara, R. R. (2016). Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine. Open forum infectious diseases, 3(1), ofw034. https://doi.org/10.1093/ofid/ofw034
Chamcha, Venkateswarlu, et al. "Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine." Open forum infectious diseases vol. 3,1 (2016): ofw034. doi: https://doi.org/10.1093/ofid/ofw034
Chamcha V, Kannanganat S, Gangadhara S, Nabi R, Kozlowski PA, Montefiori DC, LaBranche CC, Wrammert J, Keele BF, Balachandran H, Sahu S, Lifton M, Santra S, Basu R, Moss B, Robinson HL, Amara RR. Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine. Open Forum Infect Dis. 2016 Feb 11;3(1):ofw034. doi: 10.1093/ofid/ofw034. eCollection 2016 Jan. PMID: 27006959; PMCID: PMC4800464.
Copy Download .nbib Format: NLM
Facilitating support groups for siblings of children with neurodevelopmental disorders using audio-conferencing: a longitudinal feasibility study.

Child and adolescent psychiatry and mental health

Gettings S, Franco F, Santosh PJ.
PMID: 25866558
Child Adolesc Psychiatry Ment Health. 2015 Apr 07;9:8. doi: 10.1186/s13034-015-0041-z. eCollection 2015.

BACKGROUND: Siblings of children with chronic illness and disabilities are at increased risk of negative psychological effects. Support groups enable them to access psycho-education and social support. Barriers to this can include the distance they have to travel to...

Cite
Gettings S, Franco F, Santosh PJ. Facilitating support groups for siblings of children with neurodevelopmental disorders using audio-conferencing: a longitudinal feasibility study. Child Adolesc Psychiatry Ment Health. 2015;9:8doi: 10.1186/s13034-015-0041-z.
Gettings, S., Franco, F., & Santosh, P. J. (2015). Facilitating support groups for siblings of children with neurodevelopmental disorders using audio-conferencing: a longitudinal feasibility study. Child and adolescent psychiatry and mental health, 98. https://doi.org/10.1186/s13034-015-0041-z
Gettings, Sheryl, et al. "Facilitating support groups for siblings of children with neurodevelopmental disorders using audio-conferencing: a longitudinal feasibility study." Child and adolescent psychiatry and mental health vol. 9 (2015): 8. doi: https://doi.org/10.1186/s13034-015-0041-z
Gettings S, Franco F, Santosh PJ. Facilitating support groups for siblings of children with neurodevelopmental disorders using audio-conferencing: a longitudinal feasibility study. Child Adolesc Psychiatry Ment Health. 2015 Apr 07;9:8. doi: 10.1186/s13034-015-0041-z. eCollection 2015. PMID: 25866558; PMCID: PMC4392474.
Copy Download .nbib Format: NLM
Redox regulation of the Calvin-Benson cycle: something old, something new.

Frontiers in plant science

Michelet L, Zaffagnini M, Morisse S, Sparla F, Pérez-Pérez ME, Francia F, Danon A, Marchand CH, Fermani S, Trost P, Lemaire SD.
PMID: 24324475
Front Plant Sci. 2013 Nov 25;4:470. doi: 10.3389/fpls.2013.00470.

Reversible redox post-translational modifications such as oxido-reduction of disulfide bonds, S-nitrosylation, and S-glutathionylation, play a prominent role in the regulation of cell metabolism and signaling in all organisms. These modifications are mainly controlled by members of the thioredoxin and...

Cite
Michelet L, Zaffagnini M, Morisse S, et al. Redox regulation of the Calvin-Benson cycle: something old, something new. Front Plant Sci. 2013;4:470doi: 10.3389/fpls.2013.00470.
Michelet, L., Zaffagnini, M., Morisse, S., Sparla, F., Pérez-Pérez, M. E., Francia, F., Danon, A., Marchand, C. H., Fermani, S., Trost, P., & Lemaire, S. D. (2013). Redox regulation of the Calvin-Benson cycle: something old, something new. Frontiers in plant science, 4470. https://doi.org/10.3389/fpls.2013.00470
Michelet, Laure, et al. "Redox regulation of the Calvin-Benson cycle: something old, something new." Frontiers in plant science vol. 4 (2013): 470. doi: https://doi.org/10.3389/fpls.2013.00470
Michelet L, Zaffagnini M, Morisse S, Sparla F, Pérez-Pérez ME, Francia F, Danon A, Marchand CH, Fermani S, Trost P, Lemaire SD. Redox regulation of the Calvin-Benson cycle: something old, something new. Front Plant Sci. 2013 Nov 25;4:470. doi: 10.3389/fpls.2013.00470. PMID: 24324475; PMCID: PMC3838966.
Copy Download .nbib Format: NLM
A whole health economy approach to reducing MRSA bacteraemia incidence in diabetic foot ulcer patients.

Journal of infection prevention

Branton F, Cathcart E, Bellamy E.
PMID: 28989465
J Infect Prev. 2016 May;17(3):108-113. doi: 10.1177/1757177416633514. Epub 2016 Mar 08.

INTRODUCTION: Ulceration of the foot is a common problem among diabetic patients. Infection is a major risk in diabetic foot ulcers (DFU) and many of these are caused by METHODS: A collaborative approach between acute and community healthcare providers...

Cite
Branton F, Cathcart E, Bellamy E. A whole health economy approach to reducing MRSA bacteraemia incidence in diabetic foot ulcer patients. J Infect Prev. 2016;17(3):108-113doi: 10.1177/1757177416633514.
Branton, F., Cathcart, E., & Bellamy, E. (2016). A whole health economy approach to reducing MRSA bacteraemia incidence in diabetic foot ulcer patients. Journal of infection prevention, 17(3), 108-113. https://doi.org/10.1177/1757177416633514
Branton, Fiona, et al. "A whole health economy approach to reducing MRSA bacteraemia incidence in diabetic foot ulcer patients." Journal of infection prevention vol. 17,3 (2016): 108-113. doi: https://doi.org/10.1177/1757177416633514
Branton F, Cathcart E, Bellamy E. A whole health economy approach to reducing MRSA bacteraemia incidence in diabetic foot ulcer patients. J Infect Prev. 2016 May;17(3):108-113. doi: 10.1177/1757177416633514. Epub 2016 Mar 08. PMID: 28989465; PMCID: PMC5074211.
Copy Download .nbib Format: NLM
Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding.

Experimental hematology & oncology

Cugno M, Tedeschi A, Siboni SM, Stufano F, Depetri F, Franchi F, Griffini S, Peyvandi F.
PMID: 24926417
Exp Hematol Oncol. 2014 Jun 04;3:15. doi: 10.1186/2162-3619-3-15. eCollection 2014.

A 91-year-old woman affected with acquired Von Willebrand (VW) syndrome and intestinal angiodysplasias presented with severe gastrointestinal bleeding (hemoglobin 5 g/dl). Despite replacement therapy with VW factor/factor VIII concentrate qid, bleeding did not stop (eleven packed red blood cell...

Cite
Cugno M, Tedeschi A, Siboni SM, et al. Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding. Exp Hematol Oncol. 2014;3:15doi: 10.1186/2162-3619-3-15.
Cugno, M., Tedeschi, A., Siboni, S. M., Stufano, F., Depetri, F., Franchi, F., Griffini, S., & Peyvandi, F. (2014). Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding. Experimental hematology & oncology, 315. https://doi.org/10.1186/2162-3619-3-15
Cugno, Massimo, et al. "Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding." Experimental hematology & oncology vol. 3 (2014): 15. doi: https://doi.org/10.1186/2162-3619-3-15
Cugno M, Tedeschi A, Siboni SM, Stufano F, Depetri F, Franchi F, Griffini S, Peyvandi F. Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding. Exp Hematol Oncol. 2014 Jun 04;3:15. doi: 10.1186/2162-3619-3-15. eCollection 2014. PMID: 24926417; PMCID: PMC4055248.
Copy Download .nbib Format: NLM
[Centenary of the thesis of Charcot 1853-1953; pictures from an exhibit].

Rhumatologie

Francon F.
PMID: 13168058
Rhumatologie. 1954 Jan-Feb;(1):26-31.

No abstract available.

Cite
Francon F. Le centenaire de la thèse de Charcot 1853-1953; tableaux d'une exposition. [Centenary of the thesis of Charcot 1853-1953; pictures from an exhibit]. Rhumatologie. 1954;(1):26-31
Francon, F. (1954). Le centenaire de la thèse de Charcot 1853-1953; tableaux d'une exposition. [Centenary of the thesis of Charcot 1853-1953; pictures from an exhibit]. Rhumatologie, (1), 26-31.
Francon, F. "Le centenaire de la thèse de Charcot 1853-1953; tableaux d'une exposition." [Centenary of the thesis of Charcot 1853-1953; pictures from an exhibit]. Rhumatologie vol. ,1 (1954): 26-31.
Francon F. Le centenaire de la thèse de Charcot 1853-1953; tableaux d'une exposition. [Centenary of the thesis of Charcot 1853-1953; pictures from an exhibit]. Rhumatologie. 1954 Jan-Feb;(1):26-31. Undetermined. PMID: 13168058.
Copy Download .nbib Format: NLM
[Professor Laignel-Lavastine, 1875-1953].

Revue du rhumatisme et des maladies osteo-articulaires

FRANCON F.
PMID: 13156287
Rev Rhum Mal Osteoartic. 1953 Dec;20(12):851-3.

No abstract available.

Cite
FRANCON F. Le Professeur Laignel-Lavastine, 1875-1953. [Professor Laignel-Lavastine, 1875-1953]. Rev Rhum Mal Osteoartic. 1953;20(12):851-3
FRANCON, F. (1953). Le Professeur Laignel-Lavastine, 1875-1953. [Professor Laignel-Lavastine, 1875-1953]. Revue du rhumatisme et des maladies osteo-articulaires, 20(12), 851-3.
FRANCON, F. "Le Professeur Laignel-Lavastine, 1875-1953." [Professor Laignel-Lavastine, 1875-1953]. Revue du rhumatisme et des maladies osteo-articulaires vol. 20,12 (1953): 851-3.
FRANCON F. Le Professeur Laignel-Lavastine, 1875-1953. [Professor Laignel-Lavastine, 1875-1953]. Rev Rhum Mal Osteoartic. 1953 Dec;20(12):851-3. French. PMID: 13156287.
Copy Download .nbib Format: NLM
The surface variational principle applied to an acoustic cavity.

The Journal of the Acoustical Society of America

Franco F, Cunefare KA.
PMID: 11425122
J Acoust Soc Am. 2001 Jun;109(6):2797-804. doi: 10.1121/1.1369107.

This paper presents the development and application of the Surface Variational Principle (SVP) for the evaluation of axisymmetric interior acoustic domains. The interior form of the SVP is first developed in the same manner as the existing exterior form....

Cite
Franco F, Cunefare KA. The surface variational principle applied to an acoustic cavity. J Acoust Soc Am. 2001;109(6):2797-804doi: 10.1121/1.1369107.
Franco, F., & Cunefare, K. A. (2001). The surface variational principle applied to an acoustic cavity. The Journal of the Acoustical Society of America, 109(6), 2797-804. https://doi.org/10.1121/1.1369107
Franco, F, and Cunefare, K A. "The surface variational principle applied to an acoustic cavity." The Journal of the Acoustical Society of America vol. 109,6 (2001): 2797-804. doi: https://doi.org/10.1121/1.1369107
Franco F, Cunefare KA. The surface variational principle applied to an acoustic cavity. J Acoust Soc Am. 2001 Jun;109(6):2797-804. doi: 10.1121/1.1369107. PMID: 11425122.
Copy Download .nbib Format: NLM
[RAYMOND-JOSEPH WEISSENBACH (1885-1963)].

Revue medicale de la Suisse romande

FRANCON F.
PMID: 14103771
Rev Med Suisse Romande. 1963 Dec;83:1021-4.

No abstract available.

Cite
FRANCON F. RAYMOND-JOSEPH WEISSENBACH (1885-1963) [RAYMOND-JOSEPH WEISSENBACH (1885-1963)]. Rev Med Suisse Romande. 1963;83:1021-4
FRANCON, F. (1963). RAYMOND-JOSEPH WEISSENBACH (1885-1963) [RAYMOND-JOSEPH WEISSENBACH (1885-1963)]. Revue medicale de la Suisse romande, 831021-4.
FRANCON, F. "RAYMOND-JOSEPH WEISSENBACH (1885-1963)" [RAYMOND-JOSEPH WEISSENBACH (1885-1963)]. Revue medicale de la Suisse romande vol. 83 (1963): 1021-4.
FRANCON F. RAYMOND-JOSEPH WEISSENBACH (1885-1963) [RAYMOND-JOSEPH WEISSENBACH (1885-1963)]. Rev Med Suisse Romande. 1963 Dec;83:1021-4. French. PMID: 14103771.
Copy Download .nbib Format: NLM
Paget's bone disease.

Bruxelles medical

FRANCON F.
PMID: 18883023
Brux Med. 1948 Sep 12;28(38):1885-95.

No abstract available.

Cite
FRANCON F. Maladie osseuse de Paget. Paget's bone disease. Brux Med. 1948;28(38):1885-95
FRANCON, F. (1948). Maladie osseuse de Paget. Paget's bone disease. Bruxelles medical, 28(38), 1885-95.
FRANCON, F. "Maladie osseuse de Paget." Paget's bone disease. Bruxelles medical vol. 28,38 (1948): 1885-95.
FRANCON F. Maladie osseuse de Paget. Paget's bone disease. Brux Med. 1948 Sep 12;28(38):1885-95. French. PMID: 18883023.
Copy Download .nbib Format: NLM
Inhibition of mast cell histamine release by flavonoids and biflavonoids.

Planta medica

Amellal M, Bronner C, Briancon F, Haag M, Anton R, Landry Y.
PMID: 17340391
Planta Med. 1985 Feb;51(1):16-20. doi: 10.1055/s-2007-969381.

The effect of 11 flavonoids and 4 biflavonoids on the release of histamine from peritoneal rat mast cells induced by compound 48/80 and calcium ionophore A23187 was studied. Dihydroflavonoids (flavanones) and (+)-catechin did not modify histamine release induced by...

Cite
Amellal M, Bronner C, Briancon F, et al. Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med. 1985;51(1):16-20doi: 10.1055/s-2007-969381.
Amellal, M., Bronner, C., Briancon, F., Haag, M., Anton, R., & Landry, Y. (1985). Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta medica, 51(1), 16-20. https://doi.org/10.1055/s-2007-969381
Amellal, M, et al. "Inhibition of mast cell histamine release by flavonoids and biflavonoids." Planta medica vol. 51,1 (1985): 16-20. doi: https://doi.org/10.1055/s-2007-969381
Amellal M, Bronner C, Briancon F, Haag M, Anton R, Landry Y. Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med. 1985 Feb;51(1):16-20. doi: 10.1055/s-2007-969381. PMID: 17340391.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 360 entries